Page 2 - Danforth Advisors News Today

BioPharma

John Bakke, VP of Finance TEWKSBURY, Mass. - August 15, 2022 - (Newswire.com) Cambridge Isotope Laboratories, Inc., the world's leading manufacturer of stable isotopes and stable isotope...

19.07.2022 - RenovoRx, Inc. (Nasdaq: RNXT), a biopharmaceutical company and innovator in targeted cancer therapy, today is announcing the appointment of James Ahlers as Chief Financial Officer (CFO), effective July 15, 2022, and the addition of Ronald B. Kocak ... Seite 1

- Key C-suite appointments provide fiscal and culture leadership as company expandsCAMBRIDGE, Mass.--(BUSINESS WIRE)--Anji Pharma, an emerging global medicines company, today announced an expanded leadership team with the appointments of Julianne Averill as Chief Financial Officer and Kristen Richardson as Chief Peo...

CSWC Reports Pre-Tax Net Investment Income of $0.51 Per Share for Quarter Ended December 31, 2021...

/PRNewswire/ -- BioEclipse Therapeutics™ (BioEclipse), a private clinical-stage biopharmaceutical company with a proprietary platform for developing...

BioEclipse Therapeutics Appoints New Board Member and Names Interim CFO - read this article along with other careers information, tips and advice on BioSpace

OXEIA BIOPHARMACEUTICALS ANNOUNCES NEW BOARD AND MANAGEMENT TEAM MEMBERS AND RELOCATES CORPORATE HEADQUARTERS TO BOSTON - read this article along with other careers information, tips and advice on BioSpace

--Danforth Advisors, LLC today introduced a suite of risk management services to help life science companies assess and mitigate internal and external risk with flexibility and sector-informed expertise, including the design and implementation of the right combination of insurance policies. “With our broad view inside hundreds of life science companies,...

/PRNewswire/ -- Avesi Partners, LLC ("Avesi") announced that it has made an investment in Danforth Advisors, LLC ("Danforth"), the life science industrys...